Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Secondary Osteoporosis in Patient with Adult Celiac Disease (CROSBI ID 501365)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Sinčić Mijandrušić, Branka ; Crnčević Orlić, Željka ; Jurišić Eržen, Dubravka Secondary Osteoporosis in Patient with Adult Celiac Disease // Calcified tissue international / Civitelli, Roberto ; Hruska, Keith ; Ralston, Stuart (ur.). 2002. str. 282-282

Podaci o odgovornosti

Sinčić Mijandrušić, Branka ; Crnčević Orlić, Željka ; Jurišić Eržen, Dubravka

engleski

Secondary Osteoporosis in Patient with Adult Celiac Disease

Bowel diseases are frequently associated with bone loss. We have analyzed a fifty two year old woman who came to the clinic with the ilness history of diarrhea, loss of weight and old fracture of fourth left metacarpal bone. Routine laboratory test indicated malapsorption problems. Results of D-xylosa test, lipid absorption test, endomisial antibodies and jejunal biopsy confirmed the diagnosis of celiac disease. After the specific diet treatment she slowly gained weight, but body mass index (BMI) did not rise more than 20 kg/m2.After she was complaining of back pain, x-ray examination and bone densitometry were done. Low bone mineral density (BMD) values indicated osteoporosis. Biochemical markers of bone resorption confirmed an active resorption phase of bone remodeling. Parathyroid hormone (PTH) was twice the normal values. Bone biopsy and hystomorphometry established the diagnosis of hyperparathyroidism. After three mounths of treatment with biosposphonates (alendronate), vitamin D and calcium supplementation, bone markers were elevated and the patient complained less of back pain. The findings of the present case report suggest that patients with malapsorption syndrome are at high risk for bone loss. Further studies are needed to evaluate the efficacy of specific antiresorptive therapies and clinical utility of biochemical markers of bone turnover in predicting therapeutic response in these patients.

secondary osteoporosis; celiac disease

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

282-282.

2002.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Calcified tissue international

Civitelli, Roberto ; Hruska, Keith ; Ralston, Stuart

Lyon: Springer

0171-967X

Podaci o skupu

European symposium on calcified tissues (29 ; 2002)

poster

25.05.2002-29.05.2002

Zagreb, Hrvatska

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost